Len Farol

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Robert Chen, Joycelynne Palmer, Sandra H. Thomas et al. · Blood · 2012 · 131 citations · Full text

Medicine, Hematology, Immunology +14

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia

Anthony S. Stein, Joycelynne Palmer, Ni‐Chun Tsai et al. · Biology of Blood and Marrow Transplantation · 2017 · 99 citations · Full text

Medicine, Hematology, Oncology +17

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients

Ibrahim Aldoss, Corinna La Rosa, Lindsey R. Baden et al. · Annals of Internal Medicine · 2020 · 74 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial

Ryotaro Nakamura, Corinna La Rosa, Jeff Longmate et al. · The Lancet Haematology · 2015 · 72 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma

Robert Chen, Joycelynne Palmer, Ni‐Chun Tsai et al. · Biology of Blood and Marrow Transplantation · 2014 · 58 citations · Full text

Medicine, Hematology, Oncology +13